Extended Data Fig. 1: Flow chart of the REGOMUNE study.
Forty-seven patients were enrolled in the study, of whom 46 were evaluated for safety and 42 for efficacy.
Extended Data Fig. 1: Flow chart of the REGOMUNE study. | Nature Cancer
Forty-seven patients were enrolled in the study, of whom 46 were evaluated for safety and 42 for efficacy.
